These results reveal a new pro-metastatic role for NME1 in breast cancer, suggesting its function is tissue-context specific, and open the door to future studies investigating the mechanistic link between NME1 and OXPHOS and their potential as therapeutic targets for metastatic disease. The gene discussed is NME1; the disease is breast carcinoma.